@article{589e4a480f7e4744be7014ccd3ec2da9,
title = "An ALS-associated KIF5A mutant forms oligomers and aggregates and induces neuronal toxicity",
abstract = "KIF5A is a kinesin superfamily motor protein that transports various cargos in neurons. Mutations in Kif5a cause familial amyotrophic lateral sclerosis (ALS). These ALS mutations are in the intron of Kif5a and induce mis-splicing of KIF5A mRNA, leading to splicing out of exon 27, which in human KIF5A encodes the cargo-binding tail domain of KIF5A. Therefore, it has been suggested that ALS is caused by loss of function of KIF5A. However, the precise mechanisms regarding how mutations in KIF5A cause ALS remain unclear. Here, we show that an ALS-associated mutant of KIF5A, KIF5A(Δexon27), is predisposed to form oligomers and aggregates in cultured mouse cell lines. Interestingly, purified KIF5A(Δexon27) oligomers showed more active movement on microtubules than wild-type KIF5A in vitro. Purified KIF5A(∆exon27) was prone to form aggregates in vitro. Moreover, KIF5A(Δexon27)-expressing Caenorhabditis elegans neurons showed morphological defects. These data collectively suggest that ALS-associated mutations of KIF5A are toxic gain-of-function mutations rather than simple loss-of-function mutations.",
keywords = "ALS, KIF5A, aggregation",
author = "Juri Nakano and Kyoko Chiba and Shinsuke Niwa",
note = "Funding Information: We thank all of the members of the McKenney lab (UC Davis), Sugimoto lab (Tohoku University), and Niwa lab (Tohoku University) for helpful discussions. SN was supported by JSPS KAKENHI (20H03247, 19H04738, 20K21378), the Kato Memorial Bioscience Foundation, and Takeda Science Foundation. KC was supported by Uehara Memorial Foundation, JSPS KAKENHI (21K20621) and MEXT Leading Initiative for Excellent Researchers (JPMXS0320200156). Some strains and OP50 were obtained from the CGC. We thank Lisa Kreiner, PhD, from Edanz ( https://www.jp.edanz.com/ac ) for editing a draft of this manuscript. C. elegans Funding Information: Japan Society for the Promotion of Science, Grant/Award Numbers: 19H04738, 20H03247, 20K21378, 21K20621; Ministry of Education, Culture, Sports, Science & Technology, Grant/Award Number: JPMXS0320200156; Kato Memorial Bioscience Foundation; Takeda Science Foundation; Uehara Memorial Foundation Funding information Funding Information: We thank all of the members of the McKenney lab (UC Davis), Sugimoto lab (Tohoku University), and Niwa lab (Tohoku University) for helpful discussions. SN was supported by JSPS KAKENHI (20H03247, 19H04738, 20K21378), the Kato Memorial Bioscience Foundation, and Takeda Science Foundation. KC was supported by Uehara Memorial Foundation, JSPS KAKENHI (21K20621) and MEXT Leading Initiative for Excellent Researchers (JPMXS0320200156). Some C. elegans strains and OP50 were obtained from the CGC. We thank Lisa Kreiner, PhD, from Edanz (https://www.jp.edanz.com/ac) for editing a draft of this manuscript. Publisher Copyright: {\textcopyright} 2022 The Authors. Genes to Cells published by Molecular Biology Society of Japan and John Wiley & Sons Australia, Ltd.",
year = "2022",
month = jun,
doi = "10.1111/gtc.12936",
language = "English",
volume = "27",
pages = "421--435",
journal = "Genes to Cells",
issn = "1356-9597",
publisher = "Wiley-Blackwell",
number = "6",
}